Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
German foreign minister heads to China to talk rare-earth exports - 2Cognizant Couture d: A Survey of \Moral Decisions and Sharp Looks\ Maintainable Style
- 3Michael Jordan donates $10M to North Carolina medical center in honor of his mother
- 4Want to be better about saving money in 2026? Try these money-saving tips for having a ‘low-buy’ January and beyond
- 5My Pioneering Excursion: Building a Startup
- 'No Kings' protests recap: More than 8 million turned out across all 50 states, organizers say
- Russian drone slams into block of flats in deadly wave of strikes across Kyiv
- Instructions to Pick the Best Course for Your Next Waterway Voyage: Objections, Views, and Social Encounters
- Truly amazing Palaces: Which Is Your Number one?
- Wonderful Sea shores All over the Planet
- 35 million tons of food go to waste yearly in the US. Experts share tips to help stop it
- I went to Japan during peak cherry blossom season and found an easy way to escape the crowds at popular tourist attractions
- Kuwait is softening stance on Israel, dissident tells ‘Post’ after viral UN speech
- Pfizer says patient dies after receiving hemophilia drug in trial
